Gilead Sciences Inc (GILD)

GILD (NASDAQ:Drugs) EQUITY
$82.37
neg -0.60
-0.72%
Today's Range: 82.16 - 83.39 | GILD Avg Daily Volume: 10,007,100
Last Update: 09/19/17 - 2:52 PM EDT
Volume: 3,793,200
YTD Performance: 15.01%
Open: $83.39
Previous Close: $82.97
52 Week Range: $77.92 - $120.37
Oustanding Shares: 1,305,926,217
Market Cap: 107,556,083,232
6-Month Chart
TheStreet Ratings Grade for GILD
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 9 7 7 8
Moderate Buy 1 1 1 1
Hold 8 9 9 8
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.94 2.12 2.12 2.00
Latest Dividend: 0.52
Latest Dividend Yield: 2.53%
Dividend Ex-Date: 09/14/17
Price Earnings Ratio: 8.94
Price Earnings Comparisons:
GILD Sector Avg. S&P 500
8.94 8.90 36.70
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
27.08% 5.29% -18.45%
GROWTH 12 Mo 3 Yr CAGR
Revenue -6.90 1.70 0.39
Net Income -25.50 3.40 0.63
EPS -16.50 4.00 0.70
Earnings for GILD:
EBITDA 18.79B
Revenue 30.39B
Average Earnings Estimates
Qtr (09/17) Qtr (12/17) FY (12/17) FY (12/18)
Average Estimate $2.07 $1.88 $8.58 $7.11
Number of Analysts 6 5 6 6
High Estimate $2.26 $2.08 $8.90 $7.58
Low Estimate $1.90 $1.61 $8.34 $6.69
Prior Year $2.70 $2.64 $11.37 $8.58
Growth Rate (Year over Year) -23.21% -28.86% -24.51% -17.13%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands

Some Weak Names Today Real Money Pro($)

An old trading dictim is that you might consider selling or shorting stocks that are in the red when the market is broadly in the green (and vice…
But is it too late?

Getting Bullish on Gilead Real Money Pro($)

I'm setting up a risk reversal to either buy the stock lower or participate in the upside.
Today's breakout move in the stock is a highlight of the surging sector.
Today's breakout move in the stock is a highlight of the surging sector.
Buying's good for the acquirers, which should give other companies ideas.
With stock back up to $80, it's time to adjust the parameters.
Prospects for acquisition activity in the sector are improving.
That would mean that there is the chance for a comeback here of some note.
Monday's action failed to change the overall character of the market

Columnist Conversations

BBY is getting smoked this mornings(weak forecast).  The stock is off 8% after opening the session with a...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.